T-cell revival

Credit: © Eye of Science / Photo Researchers, Inc." /> Credit: © Eye of Science / Photo Researchers, Inc. The paper: D.L. Barber et al., "Restoring function in exhausted CD8 T cells during chronic viral infection," Nature, 439:682-7, 2006. (Cited in 97 papers) The finding: Rafi Ahmed at Emory Vaccine Center in Atlanta and colleagues examined microarrays from T cells that lose function during chronic lymphocytic choriomeningitis, a viral

kerry grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The paper:
D.L. Barber et al., "Restoring function in exhausted CD8 T cells during chronic viral infection," Nature, 439:682-7, 2006. (Cited in 97 papers)

The finding:
Rafi Ahmed at Emory Vaccine Center in Atlanta and colleagues examined microarrays from T cells that lose function during chronic lymphocytic choriomeningitis, a viral infection of immune cells that causes meningitis. They found a number of gene-expression changes. The most striking was an upregulation of the inhibitory receptor, programmed death 1 (PD-1) and its ligand. Blocking their interaction improved T-cell function.

The impact:
Until this study, "no one had shown [that] you could interfere immunologically and restore T-cell function," Ahmed says. The cells made more cytokines and were able to lyse targets, he adds.

The application: "There are obvious parallels to HIV, and we had to start working on it right away," says Richard Koup at the National Institute of Allergy and Infectious Diseases. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo